People: Digirad Corp (DRAD.OQ)
DRAD.OQ on NASDAQ Stock Exchange Global Market
2.44USD
4:00pm EDT
2.44USD
4:00pm EDT
Price Change (% chg)
$-0.02 (-0.81%)
$-0.02 (-0.81%)
Prev Close
$2.46
$2.46
Open
$2.45
$2.45
Day's High
$2.45
$2.45
Day's Low
$2.41
$2.41
Volume
19,968
19,968
Avg. Vol
12,315
12,315
52-wk High
$2.67
$2.67
52-wk Low
$1.80
$1.80
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Jeffrey Eberwein |
42 | 2013 | Chairman of the Board |
Matthew Molchan |
46 | 2013 | President, Chief Executive Officer, Director |
Jeffry Keyes |
39 | 2012 | Chief Financial Officer |
Virgil Lott |
54 | 2013 | President of Digirad Imaging Solutions, Inc. |
Armando Jackson |
54 | 2011 | Senior Vice President - Product Sales |
John Climaco |
43 | 2012 | Director |
Charles Gillman |
43 | 2012 | Independent Director |
James Hawkins |
57 | 2012 | Independent Director |
John Sayward |
60 | 2008 | Independent Director |
Biographies
| Name | Description |
|---|---|
Jeffrey Eberwein |
Mr. Jeffrey E. Eberwein serves as an Chairman of the Board of Digirad Corp. Mr. Eberwein has 20 years of financial sector experience including 16 years in investment management and 4 years in investment banking. Mr. Eberwein was a Portfolio Manager for 11 years, most recently at Soros Fund Management and prior to that at Viking Global Investors and Cumberland Associates. Mr. Eberwein is currently a private investor. In addition, Mr. Eberwein currently serves on the Board of Hope for New York, a 501(c)(3) organization dedicated to serving the poor in New York City. Mr. Eberwein earned an Master of Business Administration from The Wharton School, University of Pennsylvania and a Bachelors of Business Administration from The University of Texas at Austin. |
Matthew Molchan |
Mr. Matthew G. Molchan is President, Chief Executive Officer, Director of Digirad Corp. He was appointed as Chief Executive Officer, Director of the Company on July 1, 2013. He was previously Chief Operating Officer of Digirad Ultrascan Solutions from May 2007 to January 2012. He joined Digirad Ultrascan Solutions upon the acquisition of Ultrascan, Inc. by Digirad Corporation in May 2007. Prior to joining Digirad, Mr. Molchan was the CFO for Ultrascan, Inc - the southeast's mobile ultrasound business. Matt joined Ultrascan, Inc. in 2003. Prior to Ultrascan, Mr. Molchan held various executive level business development, finance and operations positions at Somera, Inc. and Equifax, Inc. Mr. Molchan holds a Bachelor of Science degree in Economics from the United States Air Force Academy and a Masters of Business Administration in finance from the University of Southern California. |
Jeffry Keyes |
Mr. Jeffry R. Keyes has been appointed as Chief Financial Officer of Digirad Corp., since September 6, 2012. Prior to joining the Company, Mr. Keyes was Corporate Controller of Sapphire Energy, Inc., a renewable energy company. Mr. Keyes joined Sapphire Energy, Inc. in August 2011. From April 2011 to August 2011, he was the Corporate Controller of Advanced BioHealing, Inc. (now Shire Regenerative Medicine), a provider of regenerative medicine solutions. From March 2009 to April 2011, Mr. Keyes was the Senior Director, External Reporting and Technical Accounting, of CareFusion, a global medical technology company. From June 2008 to February 2009, Mr. Keyes held the position of Corporate Audit Project Manager at Caterpillar Inc., a manufacturer of construction and mining equipment. Prior to joining Caterpillar Inc., Mr. Keyes was the Senior Manager, Financial Reporting for Plum Creek Timber Company, a position he assumed in October 2005. Keyes earned a Bachelor of Arts degree in accounting at Western Washington University. He is also a Certified Public Accountant. |
Virgil Lott |
Mr. Virgil J. Lott serves as President of Digirad Imaging Solutions, Inc., subsidiary of Digirad Corp. His prior positions at Digirad included Vice President of Customer Service and Operations from June 2006 to October 2009 as well as Director of Customer Service from February 2006 to June 2006. Mr. Lott has been in medical imaging field service for over 25 years, both as a field service engineer and in various field service management positions. Prior to coming to Digirad, he was the Vice President of Field Service at BC Technical, a multi-vendor service company, from April 2005 to February 2006. He also held several management positions at Philips Medical Systems and ADAC Laboratories from 1983 to May 2005, including Region Service Manager, Director of PET Customer Service, and National Installations Manager. Mr. Lott received training in electronics from the US Army and Electronic Design Engineering Technology from Capitol Radio Engineering Institute. He also holds a Bachelor of Science in business administration from California Coast University. |
Armando Jackson |
Mr. Armando Jackson serves as Senior Vice President - Product Sales of Digirad Corp., since July 11, 2011. He has over 25 years of experience sales and marketing teams in a variety of healthcare businesses and consulting firms. Prior to joining Digirad, Mr. Jackson was President and Managing Director of Sol Associates, a consulting firm focused on assisting businesses form new strategies to increase revenue and profitability. From 2007 to 2009, Mr. Jackson was Chief Executive Officer of Peak Health Solutions a healthcare services company. From 2004 to 2006 Jackson was Executive Vice President and General Manager for Alteer Corporation, a company that provided business services to physician groups. From 1997 to 2003, Mr. Jackson was with Edix Corporation. Mr. Jackson has a Bachelor’s degree in Economics from University of California at Davis. |
John Climaco |
Mr. John M. Climaco serves as Director of Digirad Corp., since May 31, 2012. Mr. Climaco is the President and Chief Executive Officer, as well as member of the board of directors, of Axial Biotech, Inc., a venture-backed molecular diagnostics company specializing in spine disorders, which he co-founded in 2003. Under Mr. Climaco's leadership, and through partnerships he created with companies including Medtronic, Johnson & Johnson and Smith & Nephew, Axial developed and commercialized ScoliScore, the first molecular prognostic test in the orthopaedic industry. Prior to founding Axial Biotech, Mr. Climaco served as Director of Programming for Quokka Sports, a venture-backed online media company that went public in 1999. While with Quokka, Mr. Climaco helped to create and manage partnerships with Intel, Microsoft WebTV, NBC Sports and National Geographic. Mr. Climaco was also an attorney with Fabian & Clendenin in Salt Lake City. Mr. Climaco currently serves on the board of directors of InfuSystem Holdings, Inc., a national provider of infusion pumps and related services. Mr. Climaco holds a Bachelor of Arts in Philosophy, cum laude, from Middlebury College and a Juris Doctorate from the University of California, Hastings College of Law. |
Charles Gillman |
Mr. Charles M. Gillman serves as an Independent Director of Digirad Corp., since April 22, 2012. Mr. Gillman has provided portfolio management services since 2001 to Nadel and Gussman, LLC, a private company that manages the assets of a single family. In mid-2009, shareholders of MRV Communications, Inc. approached Mr. Gillman about joining the Board of MRV. Mr. Gillman joined the Board of Directors of MRV in the fall of 2009. Mr. Gillman received a Bachelor of Science degree from The Wharton School, University of Pennsylvania and was a Management Consultant in the New York office of McKinsey and Company before joining the investment industry. |
James Hawkins |
Mr. James B. Hawkins serves as an Independent Director of Digirad Corp., since April 22, 2012. Mr. Hawkins has over two decades of experience as chief executive of medical device companies. Since April 2004, Mr. Hawkins has served as the President, Chief Executive Officer, and a Director of Natus Medical Incorporated, a provider of healthcare products used for the screening, detection, treatment, monitoring, and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and certain newborn conditions. Prior to joining Natus Medical, Mr. Hawkins was President, Chief Executive Officer, and a Director of Invivo Corporation, a developer and manufacturer of multi-parameter vital sign monitoring equipment, and its predecessor from, 1985 through January 2004. Mr. Hawkins also served as Secretary of Invivo from 1986 until January 2004. Mr. Hawkins has served as a Director of IRIDEX Corp. since October 2007. Mr. Hawkins holds a bachelors degree in business commerce from Santa Clara University, and a Master of Business Administration from San Francisco State University. |
John Sayward |
Mr. John W. Sayward serves as an Independent Director of Digirad Corp. From 2005 to 2007, Mr. Sayward was a partner at Nippon Heart Hospital LLC, a company that built and managed cardiovascular care hospitals in Japan. From 2002 to 2005, Mr. Sayward was the Executive Vice President and Chief Financial Officer of LMA North America Inc. From 1996 to 2001, Mr. Sayward served as the Executive Vice President of Finance, Chief Financial Officer and Treasurer of SICOR Inc., an international pharmaceutical company, and was elected to its Board of Directors in 1998. Mr. Sayward received a bachelor’s degree from Northwestern University in 1973 and a Master of Management from the Kellogg School of Management at Northwestern University in 1975. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Jeffrey Eberwein |
-- |
Matthew Molchan |
-- |
Jeffry Keyes |
-- |
Virgil Lott |
222,000 |
Armando Jackson |
-- |
John Climaco |
-- |
Charles Gillman |
-- |
James Hawkins |
-- |
John Sayward |
-- |
As Of 30 Dec 2011
Options Compensation
| Name | Options | Value |
|---|---|---|
Jeffrey Eberwein |
0 | 0 |
Matthew Molchan |
0 | 0 |
Jeffry Keyes |
0 | 0 |
Virgil Lott |
0 | 0 |
Armando Jackson |
0 | 0 |
John Climaco |
0 | 0 |
Charles Gillman |
0 | 0 |
James Hawkins |
0 | 0 |
John Sayward |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
EBERWEIN JEFFREY E |
5,000 | $2.41 |
GILLMAN CHARLES M |
5,000 | $2.41 |
EBERWEIN JEFFREY E |
5,000 | $2.45 |
GILLMAN CHARLES M |
5,000 | $2.45 |
EBERWEIN JEFFREY E |
5,000 | $2.50 |
GILLMAN CHARLES M |
5,000 | $2.50 |
EBERWEIN JEFFREY E |
1,000 | $2.51 |
GILLMAN CHARLES M |
1,000 | $2.51 |
EBERWEIN JEFFREY E |
5,000 | $2.46 |
GILLMAN CHARLES M |
5,000 | $2.46 |
EBERWEIN JEFFREY E |
5,000 | $2.44 |
GILLMAN CHARLES M |
5,000 | $2.44 |
EBERWEIN JEFFREY E |
5,000 | $2.44 |
GILLMAN CHARLES M |
5,000 | $2.44 |
EBERWEIN JEFFREY E |
5,000 | $2.45 |
GILLMAN CHARLES M |
5,000 | $2.45 |
GILLMAN CHARLES M |
5,000 | $2.46 |
EBERWEIN JEFFREY E |
5,000 | $2.46 |
EBERWEIN JEFFREY E |
5,000 | $2.45 |
GILLMAN CHARLES M |
5,000 | $2.45 |
EBERWEIN JEFFREY E |
5,000 | $2.45 |
GILLMAN CHARLES M |
5,000 | $2.45 |
GILLMAN CHARLES M |
5,000 | $2.42 |
EBERWEIN JEFFREY E |
5,000 | $2.42 |
GILLMAN CHARLES M |
5,000 | $2.42 |

